Back To Upcoming Events
Join the FDA on February 28, 2024, for an insightful webinar where they shed light on its international engagements, ensuring access to safe, effective, and high-quality generic drugs for Americans.
About the Webinar
Welcome to a comprehensive discussion on global affairs and international engagement in generic drug development, brought to you by the FDA’s Office of Generic Drugs (OGD). Discover insights from the Deputy Director at the Office of Research and Standard as he discusses the FDA and EMA’s Parallel Scientific Advice Pilot Program for Complex Generics/Hybrid Products. Learn about EMA’s international engagement strategies and gain valuable perspectives on using foreign comparators in bioequivalence studies. Engage in a dynamic panel discussion featuring distinguished panelists from CDER’s Office of Pharmaceutical Quality Policy.
Real-time attendance is mandatory for a certificate of attendance, and continuing education credits are available.
Intended Audience
This meeting is intended for members of global regulatory agencies, generic drug industry professionals, and consultants specializing in bioequivalence and clinical research coordination.
Registration
Visit the official webinar page for additional information and to register now.
Please note that an external entity hosts this event.
